Dipyridamole prevents triple-negative breast-cancer progression

Dipyridamole is a widely prescribed drug in ischemic disorders, and it is here investigated for potential clinical use as a new treatment for breast cancer. Xenograft mice bearing triple-negative breast cancer 4T1-Luc or MDA-MB-231T cells were generated. In these in vivo models, dipyridamole effects...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Metastasis
Autors principals: Spano, Daniela, Marshall, Jean-Claude, Marino, Natascia, De Martino, Daniela, Romano, Alessia, Scoppettuolo, Maria Nunzia, Bello, Anna Maria, Di Dato, Valeria, Navas, Luigi, De Vita, Gennaro, Medaglia, Chiara, Steeg, Patricia S., Zollo, Massimo
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654221/
https://ncbi.nlm.nih.gov/pubmed/22760522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-012-9506-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars